Rhythm Pharmaceuticals, Inc. — Form D/A
Rhythm Pharmaceuticals, Inc. of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2012-12-04. The offering totals $42.5M, of which $22.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-12-04
- Form: D/A
- Accession: 0001140361-12-049581
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $42.5M
- Amount sold: $22.5M
- Remaining: $20.0M
- Investors: 6
- Date of first sale: 2012-05-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-179176
Issuer
- Name: Rhythm Pharmaceuticals, Inc.
- CIK: 0001483887
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 855 Boylston Street, BOSTON, MA, 02116
- Phone: 617 428 6390
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Christian De La Tour | Director | Slough, X0 |
| Keith Gottesdiener | Director | Burlington, MA |
| Vaughan Kailian | Director | Boston, MA |
| Edward Mathers | Director | South San Francisco, CA |
| Lou Tartaglia | Director | Cambrdige, MA |
| Keith Gottesdiener | Executive Officer | Burlington, MA |
| Bart Henderson | Executive Officer | Cambridge, MA |
| Todd Foley | Director | South San Francisco, CA |
| Bart Henderson | Director | Cambridge, MA |
| Steven St. Peter | Director | Kansas City, KS |
Other filings by this issuer (3)
More